Products Categories
Basic Information
| CAS No.: | 864084-88-8 |
|---|---|
| Name: | OPIORPHIN |
| Article Data: | 4 |
| Molecular Structure: | |
|
|
|
| Formula: | C29H48 N12 O8 |
| Molecular Weight: | 692.776 |
| Synonyms: | 10: PN:EP1577320 SEQID: 3 claimed protein; 1: PN: WO2009090265 SEQID: 1 claimedprotein; 23: PN: US20090042208 SEQID: 23 claimed protein; Opiorphin; Opiorphin(human) |
| PSA: | 366.84000 |
| LogP: | 0.71060 |
Related products
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
- 894852-01-87-BROMO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE
- 90221-55-92-bromo-5-methylbenzaldehyde
- 885590-99-82,3-DIFLUORO-4-IODOBENZALDEHYDE
- 97730-31-9(S)-4'-(2-Methylbutyl)Biphenyl-4-Carbonitrile
- 926293-55-26-Bromo-2-methylpyridine-3-carboxaldehyde
- 911112-05-55-Iodo-3-(trifluoromethyl)-2-pyridinamine
- 886364-50-71-(5-Bromo-2-pyridinyl)-2,2,2-trifluoroethanone
Synthetic route
- 35661-40-6
N-Fmoc L-Phe
- 71989-33-8
Fmoc-Ser(tBu)-OH
- 132327-80-1
Fmoc-L-Gln(Trt)-OH
- 864084-88-8
human opiorphin
Conditions
| Conditions | Yield |
|---|---|
| Stage #1: Fmoc-Arg(Pbf)-Wang resin With piperidine In N,N-dimethyl-formamide solid phase reaction; Stage #2: Fmoc-Ser(tBu)-OH With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide for 2h; solid phase reaction; Stage #3: N-Fmoc L-Phe; Fmoc-L-Gln(Trt)-OH; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages; |
...Expand
- 35661-40-6
N-Fmoc L-Phe
- 71989-33-8
Fmoc-Ser(tBu)-OH
- 132327-80-1
Fmoc-L-Gln(Trt)-OH
- 864084-88-8
human opiorphin
Conditions
| Conditions | Yield |
|---|---|
| Stage #1: Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine With N-ethyl-N,N-diisopropylamine In dichloromethane solid phase reaction; Stage #2: With piperidine In N,N-dimethyl-formamide for 0.166667h; solid phase reaction; Stage #3: N-Fmoc L-Phe; Fmoc-Ser(tBu)-OH; Fmoc-L-Gln(Trt)-OH; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages; | 23.4 mg |
...Expand
- 35661-40-6
N-Fmoc L-Phe
- 132327-80-1
Fmoc-L-Gln(Trt)-OH
- 91000-69-0
Fmoc-L-Arg-OH
- 71989-33-8, 128107-47-1
Nα-(9-fluorenylmethoxycarbonyl)-D-serine-tert-butyl ether
- 864084-88-8
human opiorphin
Conditions
| Conditions | Yield |
|---|---|
| Stage #1: Fmoc-Arg(Pmc)-WANG resin With piperidine In N,N-dimethyl-formamide solid phase reaction; Stage #2: Nα-(9-fluorenylmethoxycarbonyl)-D-serine-tert-butyl ether With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide Stage #3: N-Fmoc L-Phe; Fmoc-L-Gln(Trt)-OH; Fmoc-L-Arg-OH Further stages; |
...Expand
- 35661-40-6
N-Fmoc L-Phe
- 71989-33-8
Fmoc-Ser(tBu)-OH
- 132327-80-1
Fmoc-L-Gln(Trt)-OH
- 119831-72-0
Fmoc-Arg(Pbf)-OH
- 864084-88-8
human opiorphin
Conditions
| Conditions | Yield |
|---|---|
| Stage #1: Fmoc-Arg(Pmc)-WANG resin With piperidine In N,N-dimethyl-formamide WANG resin; Stage #2: Fmoc-Ser(tBu)-OH With benzotriazol-1-ol; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide WANG resin; Stage #3: N-Fmoc L-Phe; Fmoc-L-Gln(Trt)-OH; Fmoc-Arg(Pbf)-OH Further stages; |
...Expand
